Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Jun-30-23 | Jul-01-22 | Jul-02-21 | Jul-03-20 | Jun-28-19 | Jun-29-18 | Jun-30-17 | Jul-01-16 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Singapore | 3,271 | 5,322 | 5,180 | 5,032 | 5,085 | 5,445 | 5,070 | 5,354 |
United States | 3,053 | 4,694 | 3,656 | 3,583 | 3,310 | 3,719 | 3,535 | 3,376 |
The Netherlands | 1,046 | 1,627 | 1,825 | 1,572 | 1,630 | 1,598 | 1,501 | 1,813 |
Other | | | | | | | | 617 |
Other | 14 | 18 | 20 | 322 | 365 | 422 | 665 | |
Total revenues | 7,384 | 11,661 | 10,681 | 10,509 | 10,390 | 11,184 | 10,771 | 11,160 |
Revenue growth [+] | -36.7% | 9.2% | 1.6% | 1.1% | -7.1% | 3.8% | -3.5% | -18.8% |
Singapore | -38.5% | 2.7% | 2.9% | -1.0% | -6.6% | 7.4% | -5.3% | -21.8% |
United States | -35.0% | 28.4% | 2.0% | 8.2% | -11.0% | 5.2% | 4.7% | -14.1% |
The Netherlands | -35.7% | -10.8% | 16.1% | -3.6% | 2.0% | 6.5% | -17.2% | -20.9% |
Other | | | | | | | | -8.6% |
Cost of goods sold | 6,033 | 8,192 | 7,764 | 7,667 | 7,458 | 7,820 | 7,597 | 8,545 |
Gross profit | 1,351 | 3,469 | 2,917 | 2,842 | 2,932 | 3,364 | 3,174 | 2,615 |
Gross margin | 18.3% | 29.7% | 27.3% | 27.0% | 28.2% | 30.1% | 29.5% | 23.4% |
Selling, general and administrative | 491 | 559 | 502 | 473 | 453 | 562 | 606 | 635 |
Research and development | 797 | 941 | 903 | 973 | 991 | 1,026 | 1,232 | 1,237 |
Other operating expenses | -167 | | | | | | | 123 |
EBITDA [+] | 740 | 2,409 | 1,897 | 1,761 | 2,006 | 2,321 | 1,981 | 1,435 |
EBITDA growth | -69.3% | 27.0% | 7.7% | -12.2% | -13.6% | 17.2% | 38.0% | -51.0% |
EBITDA margin | 10.0% | 20.7% | 17.8% | 16.8% | 19.3% | 20.8% | 18.4% | 12.9% |
Depreciation | 504 | 431 | 368 | 326 | 464 | 487 | 581 | 641 |
EBITA | 236 | 1,978 | 1,529 | 1,435 | 1,542 | 1,834 | 1,400 | 794 |
EBITA margin | 3.2% | 17.0% | 14.3% | 13.7% | 14.8% | 16.4% | 13.0% | 7.1% |
Amortization of intangibles | 9 | 20 | 29 | 53 | 77 | 111 | 168 | 174 |
EBIT [+] | 227 | 1,958 | 1,500 | 1,382 | 1,465 | 1,723 | 1,232 | 620 |
EBIT growth | -88.4% | 30.5% | 8.5% | -5.7% | -15.0% | 39.9% | 98.7% | -70.3% |
EBIT margin | 3.1% | 16.8% | 14.0% | 13.2% | 14.1% | 15.4% | 11.4% | 5.6% |
Non-recurring items [+] | 569 | 3 | 8 | 82 | -22 | 89 | 178 | 175 |
Asset impairment | 167 | | | | | | | |
Loss on contingent liability | 300 | | | | | | | |
Interest expense, net [+] | 303 | 247 | 218 | 181 | 140 | 198 | 210 | 190 |
Interest expense | 313 | 249 | 220 | 201 | 224 | 236 | 222 | 193 |
Interest income | 10 | 2 | 2 | 20 | 84 | 38 | 12 | 3 |
Other income (expense), net [+] | 149 | -29 | 74 | -87 | 25 | -18 | -29 | 19 |
Gain (loss) on debt retirement | 190 | | | | | | | |
Other | -41 | -29 | 74 | -87 | 25 | -18 | -29 | 19 |
Pre-tax income | -496 | 1,679 | 1,348 | 1,032 | 1,372 | 1,418 | 815 | 274 |
Income taxes | 33 | 30 | 34 | 28 | -640 | 236 | 43 | 26 |
Tax rate | | 1.8% | 2.5% | 2.7% | | 16.6% | 5.3% | 9.5% |
Net income | -529 | 1,649 | 1,314 | 1,004 | 2,012 | 1,182 | 772 | 248 |
Net margin | -7.2% | 14.1% | 12.3% | 9.6% | 19.4% | 10.6% | 7.2% | 2.2% |
|
Basic EPS [+] | ($2.56) | $7.50 | $5.43 | $3.83 | $7.13 | $4.10 | $2.61 | $0.83 |
Growth | -134.1% | 38.0% | 41.7% | -46.3% | 73.8% | 57.4% | 214.4% | -84.6% |
Diluted EPS [+] | ($2.56) | $7.36 | $5.36 | $3.79 | $7.06 | $4.05 | $2.58 | $0.82 |
Growth | -134.7% | 37.3% | 41.6% | -46.3% | 74.4% | 56.8% | 214.4% | -84.4% |
|
Dividends per share [+] | $2.80 | $2.77 | $2.66 | $2.58 | $2.52 | $2.52 | $2.52 | $2.43 |
Growth | 1.1% | 4.1% | 3.1% | 2.4% | 0.0% | 0.0% | 3.7% | 18.5% |
|
Shares outstanding (basic) [+] | 207 | 220 | 242 | 262 | 282 | 288 | 296 | 299 |
Growth | -5.9% | -9.1% | -7.6% | -7.1% | -2.1% | -2.7% | -1.0% | -7.7% |
Shares outstanding (diluted) [+] | 207 | 224 | 245 | 265 | 285 | 292 | 299 | 302 |
Growth | -7.6% | -8.6% | -7.5% | -7.0% | -2.4% | -2.3% | -1.0% | -8.8% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|